Paul Meyers

14PUBLICATIONS
116CO-AUTHORS
Molecular targetsHaematological tumoursCancer geneticsPharmacogenomicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 07, 2025
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results.

Emily K Slotkin, Audrey Mauguen, Filemon S Dela Cruz

|Oct 15, 2024
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma.

Sujana Movva, Kenneth Seier, Viswatej Avutu

|Jul 02, 2024
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.

Paul A Meyers, Noah Federman, Najat Daw

|Apr 18, 2024
Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series.

Priya H Marathe, Valeria Santibanez, Paul A Meyers

|Feb 09, 2024
Chromoplexy Is a Frequent Early Clonal Event in EWSR1-Rearranged Round Cell Sarcomas That Can Be Detected Using Clinically Validated Targeted Sequencing Panels.

Josephine K Dermawan, Emily Slotkin, William D Tap

|Oct 09, 2023
Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma.

Michael D Kinnaman, Simone Zaccaria, Alvin Makohon-Moore

Pageof 3

Frequent Collaborators

7 joint publications

Emily Slotkin

6 joint publications

William D Tap

5 joint publications

Ahmet Zehir

3 joint publications

Marc Ladanyi